Search This Blog

Thursday, July 18, 2019

Medicare to cover Novocure’s Optune for brain cancer

Novocure (NASDAQ:NVCR) announces that Medicare will cover Optune (Tumor Treating Fields) for newly diagnosed glioblastoma effective September 1.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)